JW Shinyak Corporation, a pharmaceutical company, engages in the production and sale of medicines and medical supplies in South Korea. The company offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants. It also develops prostate cancer treatment, liver cancer treatment, rheumatoid arthritis treatment, etc. using immune cells. The company was founded in 1981 and is based in Seoul, South Korea.
The current price of 067290.KQ is ₩2,335.00 KRW — it has increased by +13.08% in the past 24 hours. Watch JW Shinyak stock price performance more closely on the chart.
What is JW Shinyak stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange JW Shinyak stocks are traded under the ticker 067290.KQ.
Is JW Shinyak stock price growing?▼
067290.KQ stock has risen by +72.32% compared to the previous week, the month change is a +47.88% rise, over the last year JW Shinyak has showed a +43.71% increase.
What is JW Shinyak market cap?▼
Today JW Shinyak has the market capitalization of 124.27B
What is JW Shinyak revenue for the last year?▼
JW Shinyak revenue for the last year amounts to 186.03B KRW.
What is JW Shinyak net income for the last year?▼
067290.KQ net income for the last year is 10.16B KRW.
Does JW Shinyak pay dividends?▼
Yes, 067290.KQ dividends are paid annual. The last dividend per share was 57.14 KRW. As of today, Dividend Yield (FWD)% is 0%.
How many employees does JW Shinyak have?▼
As of June 20, 2026, the company has 235 employees.
In which sector is JW Shinyak located?▼
JW Shinyak operates in the Health & Wellness sector.
When did JW Shinyak complete a stock split?▼
The last stock split for JW Shinyak was on December 30, 2025 with a ratio of 1.05:1.
Where is JW Shinyak headquartered?▼
JW Shinyak is headquartered in Seoul, South Korea.